M&A Deal Summary |
|
|---|---|
| Date | 2014-07-02 |
| Target | Apica Cardiovascular |
| Sector | Medical Products |
| Buyer(s) | Thoratec |
| Deal Type | Add-on Acquisition |
| Deal Value | 75M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Medical Products |
| Employees | 950 |
| Revenue | 503M USD (2013) |
Thoratec Corporation is a medical device company with a product portfolio for treating advanced heart failure patients. Thoratec develops, manufactures and markets proprietary medical devices used for circulatory support. Thoratec Corporation was established in 1976 and is headquartered in Pleasanton, California.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Medical Products M&A | 5 of 5 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2014 M&A | 1 of 1 |
| Size (of disclosed) | 3 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-01 |
Terumo-DuraHeart II Ventricular Assist System
Japan DuraHeart II ventricular assist system, is an ultra-compact, full-support, centrifugal flow chronic VAD utilizing a unique technology foundation known as "force balance" suspension. The device utilizes primary magnetic forces, balanced by hydrodynamic support, to achieve consistent gaps across the operating range of the pump, independent of pump speed. |
Buy | $57M |